Skip to Content

THC Biomed International Ltd THCBF

Rating as of

Morningstar’s Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

THC Biomed International Ltd operates as a licensed producer under Canada's Marijuana for Medical Purposes Regulations (MMPR). It is also engaged in the research and development of the products and services to medical marihuana. In addition, it is also engaged in providing horticulture training, record keeping and documenting research studies, and analytical services. Geographically all the activities are carried out through the region of Canada.

1340 St. Paul Street
Kelowna, BC, V1Y 2E1, Canada
T +1 250 870-2512
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Oct 31, 2021
Fiscal Year End Jul 31, 2022
Stock Type
Employees 45